0001213900-20-022562.txt : 20200817 0001213900-20-022562.hdr.sgml : 20200817 20200817190211 ACCESSION NUMBER: 0001213900-20-022562 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200813 FILED AS OF DATE: 20200817 DATE AS OF CHANGE: 20200817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaplan Myron CENTRAL INDEX KEY: 0001672645 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 201111206 MAIL ADDRESS: STREET 1: C/O KLEINBERG, KAPLAN, WOLFF & COHEN, PC STREET 2: 551 FIFTH AVENUE, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10176 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 CONNELL DRIVE STREET 2: SUITE 5000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 400 CONNELL DRIVE STREET 2: SUITE 5000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 doc4.xml PRIMARY DOCUMENT X0306 4 2020-08-13 false 0001410098 CorMedix Inc. CRMD 0001672645 Kaplan Myron C/O CORMEDIX INC. 400 CONNELL DRIVE, SUITE 5000 BERKELEY HEIGHTS NJ 07922 true false false false Common Stock 2020-08-13 4 P false 15000.0000 4.0773 A 134734.0000 D Stock Option (Right to Buy Common Stock) 5.6300 2030-02-25 Common Stock 15000.0000 15000.0000 D Stock Option (Right to Buy Common Stock) 8.3000 2029-01-10 Common Stock 15000.0000 15000.0000 D Stock Option (Right to Buy Common Stock) 2.8500 2028-02-16 Common Stock 8000.0000 8000.0000 D Stock Option (Right to Buy Common Stock) 11.2000 2027-02-21 Common Stock 8000.0000 8000.0000 D Stock Option (Right to Buy Common Stock) 21.4000 2026-04-28 Common Stock 10000.0000 10000.0000 D This transaction was executed in multiple trades at prices ranging from $4.04 to $4.0899. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. These options were granted on 01/10/2019. These options are fully vested. These options were granted on 02/16/2018. These options are fully vested. These options were granted on 02/21/2017. These options are fully vested. These options were granted on 4/28/2016. These options are fully vested. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Myron Kaplan 2020-08-17